MATUCCI, Andrea
 Distribuzione geografica
Continente #
NA - Nord America 2.143
EU - Europa 1.685
AS - Asia 1.308
SA - Sud America 188
AF - Africa 9
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.339
Nazione #
US - Stati Uniti d'America 2.096
GB - Regno Unito 685
SG - Singapore 553
CN - Cina 484
BR - Brasile 167
IT - Italia 157
SE - Svezia 153
HK - Hong Kong 145
DE - Germania 127
FR - Francia 124
FI - Finlandia 116
RU - Federazione Russa 116
IE - Irlanda 109
KR - Corea 60
UA - Ucraina 42
CA - Canada 36
BE - Belgio 19
TR - Turchia 13
IN - India 9
JP - Giappone 9
PL - Polonia 9
ES - Italia 7
MX - Messico 7
AR - Argentina 6
IQ - Iraq 6
AT - Austria 5
IL - Israele 5
AU - Australia 4
EC - Ecuador 4
UZ - Uzbekistan 4
VN - Vietnam 4
BD - Bangladesh 3
CL - Cile 3
ID - Indonesia 3
VE - Venezuela 3
ZA - Sudafrica 3
BO - Bolivia 2
CH - Svizzera 2
CZ - Repubblica Ceca 2
EG - Egitto 2
JO - Giordania 2
KE - Kenya 2
KZ - Kazakistan 2
LT - Lituania 2
LV - Lettonia 2
NL - Olanda 2
PH - Filippine 2
PY - Paraguay 2
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
CR - Costa Rica 1
CV - Capo Verde 1
EU - Europa 1
GR - Grecia 1
GY - Guiana 1
HU - Ungheria 1
JM - Giamaica 1
LU - Lussemburgo 1
MA - Marocco 1
NI - Nicaragua 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PK - Pakistan 1
RO - Romania 1
SI - Slovenia 1
TL - Timor Orientale 1
Totale 5.339
Città #
Southend 636
Jacksonville 357
Chandler 293
Singapore 230
Dallas 177
Woodbridge 161
Ann Arbor 145
Hong Kong 145
Ashburn 113
Dublin 108
Houston 105
Beijing 74
Nanjing 55
Lawrence 42
New York 42
Princeton 42
Wilmington 40
Jinan 35
Verona 34
Munich 32
Boardman 31
Los Angeles 30
Seattle 27
The Dalles 27
Sindelfingen 25
Hebei 24
Seoul 23
Shenyang 23
Helsinki 22
Changsha 21
Milan 21
Nanchang 21
Tianjin 20
Brussels 18
Hangzhou 18
Zhengzhou 18
Taizhou 17
Buffalo 15
Haikou 15
Ningbo 15
Cambridge 14
Elora 14
São Paulo 14
Turku 14
Jiaxing 13
Columbus 12
Council Bluffs 12
Taiyuan 11
Montreal 10
San Francisco 10
Chicago 9
Cagliari 8
Tokyo 8
Clearwater 7
Warsaw 7
Bologna 6
Frankfurt am Main 6
Fuzhou 6
Lanzhou 6
Norwalk 6
Redmond 6
Santa Clara 6
Toronto 6
Guangzhou 5
London 5
Arco 4
Brooklyn 4
Dongguan 4
Lancaster 4
Mexico City 4
Redondo Beach 4
Rome 4
Roubaix 4
Tashkent 4
Atlanta 3
Belo Horizonte 3
Bexley 3
Brasília 3
Chennai 3
Cinisello Balsamo 3
Fairfield 3
Johannesburg 3
Kent 3
Moscow 3
Pagani 3
Redwood City 3
San Lazzaro Di Savena 3
São Bernardo do Campo 3
Washington 3
Alexandria 2
Alveslohe 2
Amman 2
Anápolis 2
Baghdad 2
Belém 2
Berlin 2
Betim 2
Birmingham 2
Boston 2
Bursa 2
Totale 3.621
Nome #
New immunogens for the induction of broad spectrum neutralizing antibodies against human immunodeficiency virus type 1 (HIV-1) 190
Autologous cellular vaccine overcomes cancer immunoediting in a mouse model of myeloma 166
Studio di immunogeni per l'induzione di anticorpi neutralizzati ad ampio spettro contro il virus dell'immunodeficienza umana (HIV-1) 164
Broad spectrum neutralizing antibodies against HIV-1 elicited by immunizing with fusion complexes and CD4-independent gp120/41s. 158
HLA-C is necessary for optimal HIV-1 infection of human peripheral blood CD4 lymphocytes 157
Fusion complexes and CD4-independent Env for the induction of broad spectrum neutralizing antibodies against HIV-1 156
Induction of human immunodeficiency virus neutralizing antibodies using fusion complexes 155
Induction and expansion of an anti-tumor immune response by B7-1+ tumor cells in dependence on the anatomical site of delivery and the dose applied 152
Fusion complexes and CD4-independent gp120s for the induction of HIV-1 neutralizing antibodies 151
Expression of HIV-1 NDK m9 env gene in eukaryotic cells for the induction of HIV-1 neutralizing antibodies 151
Broad spectrum neutralizing monoclonal antibodies against HIV-1 elicited by immunizing with fusion complexes 150
Presence and role of HLA-C in HIV-1 infection 145
Analysis of mammalian scrapie protein by novel monoclonal antibodies recognizing distinct prion protein glycoforms: an immunoblot and immunohistochemical study at the light and electron microscopic levels. 139
Temperature-dependent decay of wheat germ agglutinin activity and its implications for food processing and analysis 136
Fusion complexes and CD4-independene Env for the induction of broad spectrum neutralizing antibodies against HIV-1 136
Demonstration of the role of HLA-C in HIV-1 infection by siRNA silencing 133
Fusion complexes as immunogens for the induction of broad spectrum neutralizing antibodies against HIV-1 132
Expression of HIV-1 NDK m7 and m9 env genes in eukaryotic cells for the induction of HIV-1 neutralizing antibodies 130
Induction of HIV-1 neutralizing antibodies by fusion complexes 129
Fusion efficiency between the HIV-1 envelope and the target cell membrane is enhanced by the presence of HLA-C molecules 126
Induction of an antitumour adaptive immune response elicited by tumour cells expressing de novo B7-1 mainly depends on the anatomical site of their delivery: the dose applied regulates the expansion of the response 124
Induction of human immunodeficiency virus (HIV) neutralizing antibodies with fusion complexes 118
Expression and purification of recombinant HTLV-2 Tax protein in mammalian cells 118
Broad spectrum neutralizing antibodies against HIV-1 elicited by immunizing with fusion complexes 113
HLA-C increases fusion efficiency between the HIV-1 envelope and the cell membrane and is part of the fusion complex 111
Studies on the joint cytotoxicity of wheat germ agglutinin and monensin 110
Broad spectrum neutralizing antibodies against HIV-1 elicited by immunizing with fusion complexes 103
Fusion complexes and CD4-independent gp120s for the induction of HIV-1 neutralizing antibodies 102
Fusion complexes and CD4-independent gp120s for the induction of broad spectrum anti HIV-1 neutralizing antibodies 98
Asthma in a large COVID-19 cohort: Prevalence, features, and determinants of COVID-19 disease severity 97
HLA-C increases HIV-1 infectivity and is associated with gp120 94
Fusion complexes as broad spectrum anti-HIV vaccine 91
Induction of human immunodeficiency virus (HIV) broad spectrum neutralizing antibodies with fusion complexes. 90
COVID-19 in severe asthmatic patients during ongoing treatment with biologicals targeting type 2 inflammation: Results from a multicenter Italian survey 89
Presence and Role of HLA-C in HIV-1 Infection 86
Use of gp120-CD4-coreceptor fusion complexes and CD4-independent gp120s for the induction of HIV-1 neutralizing antibodies 81
Studio di nuovi immunogeni per l'induzione di anticorpi neutralizzanti ad ampio spettro contro il virus dell'immunodeficienza umana (HIV-1) 80
HLA-C increase fusion efficiency between the HIV-1 envelope and the cell membrane and is part of the fusion complex 78
Induction of HIV neutralizing antibodies using fusion complexes and a CD4-independent env 74
Asthma control in severe asthmatics under treatment with omalizumab: A cross-sectional observational study in Italy 68
Choosing wisely: practical considerations on treatment efficacy and safety of asthma in the elderly 62
Changes in the Adaptive Cellular Repertoire after Infection with Different SARS-CoV-2 VOCs in a Cohort of Vaccinated Healthcare Workers 58
HLA class I increases the efficiency of fusion between the HIV-1 envelope and the target cell membrane and is parte of the fusion complex between the gp120/gp41 and the cellular receptors. 57
Study of the optimal conditions for obtaining fusion complexes to be used as broad spectrum anti HIV-1 vaccine 55
Persistence of both reversible airway obstruction and higher blood eosinophils may predict lung function decline in severe asthma 42
Higher blood eosinophil levels after omalizumab treatment may be associated with poorer asthma outcomes 42
Immune signature in vaccinated versus non-vaccinated aged people with COVID-19 pneumonia 38
null 33
null 32
HLA-C increases HIV-1 infectivity 21
Managing Patients with Hypereosinophilic Syndrome: A Statement from the Italian Society of Allergy, Asthma, and Clinical Immunology (SIAAIC) 19
Tezepelumab in patients with allergic and eosinophilic asthma 19
Multidisciplinary Decision-Making—ITAlian Consensus After Two Years of Real Practice on the Management of Severe Uncontrolled CRSwNP by Biologics (ITACA Study) 12
Totale 5.371
Categoria #
all - tutte 20.221
article - articoli 9.156
book - libri 0
conference - conferenze 10.347
curatela - curatele 0
other - altro 718
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.442


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021324 0 0 34 33 54 57 6 38 43 10 44 5
2021/2022361 42 107 4 30 5 6 3 22 12 9 32 89
2022/2023843 69 101 76 130 86 193 3 55 91 8 20 11
2023/2024376 13 37 24 47 46 56 11 25 3 30 44 40
2024/20251.135 39 71 18 133 44 37 83 46 209 107 90 258
2025/2026566 255 127 184 0 0 0 0 0 0 0 0 0
Totale 5.371